Roussel Sells Parisian Offices

17 July 1994

- Roussel Uclaf is selling its offices in the Boulevard des Invalides in Paris, France. The move is in keeping with the company's decision to base its offices in Romainville. The offices are being acquired by the regional council of Ile de France for 815 million French francs ($154.8 million). Meantime, Roussel, together with parent company Hoechst, is reportedly negotiating to acquire a pharmaceuticals company in the USA, where it only has a 1% market share of the ethical pharmaceuticals market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight